Sophie Davies: Patients Often Don’t Consider Supplements to Be ‘Medications’
Sophie Davies, Training and Development Supervisor at Bespoke Clinical Services, shared a post on LinkedIn:
“One observation I’ve made during my experience as a clinical pharmacist is that patients often don’t consider supplements to be ‘medications’, so they don’t always mention them during reviews.
During some anticoagulant safety searches, I identified several patients taking omega-3/cod liver oil supplements alongside DOAC therapy.
They were all unaware of the potential additive bleeding risk.
This reinforced how important clear medicine counselling and thorough medication reviews are in reducing preventable harm.
The goal is to translate guidance into practical, usable information to keep patients fully informed.
Small interventions can have a significant impact on patient safety.”
Stay updated with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion